Use of ramipril in preventing stroke: double blind randomised trial

BMJ : British Medical Journal
Jackie BoschHOPE Investigators. Heart outcomes prevention evaluation

Abstract

To determine the effect of the angiotensin converting enzyme inhibitor ramipril on the secondary prevention of stroke. Randomised controlled trial with 2x2 factorial design. 267 hospitals in 19 countries. 9297 patients with vascular disease or diabetes plus an additional risk factor, followed for 4.5 years as part of the HOPE study. Stroke (confirmed by computed tomography or magnetic resonance imaging when available), transient ischaemic attack, and cognitive function. Blood pressure was recorded at entry to the study, after 2 years, and at the end of the study. Reduction in blood pressure was modest (3.8 mm Hg systolic and 2.8 mm Hg diastolic). The relative risk of any stroke was reduced by 32% (156 v 226) in the ramipril group compared with the placebo group, and the relative risk of fatal stroke was reduced by 61% (17 v 44). Benefits were consistent across baseline blood pressures, drugs used, and subgroups defined by the presence or absence of previous stroke, coronary artery disease, peripheral arterial disease, diabetes, or hypertension. Significantly fewer patients on ramipril had cognitive or functional impairment. Ramipril reduces the incidence of stroke in patients at high risk, despite a modest reduction in blood pr...Continue Reading

References

Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsP Sleight

❮ Previous
Next ❯

Citations

Apr 19, 2005·Der Internist·A Hartmann, S Moskau
Sep 21, 2004·Der Nervenarzt·R Scheid, H Voigt
Apr 6, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Irmgard Tegeder, Gerd Geisslinger
May 6, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Christian WernerMichael Böhm
Jul 20, 2004·Current Hypertension Reports·Bryan Williams
May 7, 2004·Current Hypertension Reports·Olivier HanonFrançoise Forette
Jan 3, 2006·Current Hypertension Reports·Ihab HajjarBrandy Frost
May 9, 2007·Current Treatment Options in Cardiovascular Medicine·Brian R Chambers, Neil G Roberts
Oct 2, 2002·Current Treatment Options in Neurology·Brett L. Cucchiara, Scott E. Kasner
May 11, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Deborah A Levine, Kenneth M Langa
Jun 5, 2003·The American Journal of Cardiology·Jeff S Healey, Stuart J Connolly
May 24, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shusuke YagiMasataka Sata
May 14, 2010·Journal of Human Hypertension·T H WesthoffJ Gallinat
Aug 30, 2008·The New England Journal of Medicine·Salim YusufUNKNOWN PRoFESS Study Group
Jun 12, 2009·British Medical Bulletin·Nitin Purandare
Mar 21, 2006·The Neurologist·Nerses Sanossian, Bruce Ovbiagele
Dec 13, 2005·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Louis R Caplan, Norman R Hertzer
Jul 12, 2007·The Neurologist·Robert J Wityk
May 26, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P Appelros, A G Andersson
Oct 25, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·G MathurG K Davis
Jul 31, 2002·The Journal of Clinical Hypertension·Domenic A Sica, Michael Weber
Aug 31, 2002·BMJ : British Medical Journal·Andrew P Wakeman, Jacqueline G Wakeman
Jan 4, 2003·BMJ : British Medical Journal·Salim YusufPeter Sleight
Jan 11, 2003·BMJ : British Medical Journal·Bryan Williams
Jan 17, 2004·BMJ : British Medical Journal·Martin Knapp
Feb 7, 2004·BMJ : British Medical Journal·Keith W Muir
Dec 14, 2004·BMJ : British Medical Journal·John AttiaChristopher R Levi
May 15, 2008·Cerebrovascular Diseases·UNKNOWN European Stroke Organisation (ESO) Executive Committee, UNKNOWN ESO Writing Committee
Oct 22, 2009·International Archives of Medicine·Shaheen E Lakhan, Michael T Sapko
Apr 15, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yasuhiro HasegawaUNKNOWN PROGRESS CT Substudy Investigators
Dec 30, 2011·PloS One·Lun Yang, Pankaj Agarwal
Mar 31, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Fintan O'RourkeAshfaq Shuaib
Sep 23, 2010·Vascular Health and Risk Management·Suzanne A LigthartEdo Richard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.